- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0013405

Dermatrait Pharmaceuticals Private Limited
About Dermatrait Pharmaceuticals Private Limited
Data last updated:
Dermatrait Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2021PTC380797.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinay Kumar Jha and Gouri Ojha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 63/36 2nd Floor Najafgarh Road Industrial Area New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹77 (net margin 0%) and EBITDA of ₹105 (EBITDA margin 0%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years.
Dermatrait Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0013405).
Company details
Recognitions & Rankings of Dermatrait Pharmaceuticals
Contact details
Dermatrait Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address63/36 2nd Floor Najafgarh Road Industrial Area New Delhi, Delhi, India – 110015
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Dermatrait Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dermatrait Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dermatrait Pharmaceuticals Private Limited, buy the company report.
Financials of Dermatrait Pharmaceuticals Private Limited
FY 2025 filings availableDermatrait Pharmaceuticals Private Limited reported revenue of ₹2.17 Lakh (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over three years, including a 7% fall in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹105 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹77 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0% | |||
| Net Profit Margin | 0% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dermatrait Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dermatrait Pharmaceuticals Private Limited
Dermatrait Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Kumar Jha | Director | 04 May 2021 | 5 Years 6 Months | Current |
| Gouri Ojha | Director | 04 May 2021 | 5 Years 6 Months | Current |
Peer comparison
Dermatrait Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apricus Pharmaceuticals Private Limited | ₹2.19 Lakh (FY 2021) | Neemrana, Rajasthan, India | ||||
| Elmus Pharmaceuticals Private Limited | ₹2.19 Lakh (FY 2019) | 2090.0% | Hyderabad, Telangana, India | |||
| Nevariss Pharmaceuticals Private Limited | ₹2.17 Lakh (FY 2025) | -60.0% | Delhi, India | |||
| Dermatrait Pharmaceuticals Private Limitedthis company | ₹2.17 Lakh (FY 2025) | ₹77 | 0% | -7.0% | Delhi, India | |
| Restogal Pharmaceuticals Private Limited | ₹2.16 Lakh (FY 2024) | -68.0% | Gurugram, Haryana, India |
To see the full peer comparison of Dermatrait Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dermatrait Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dermatrait Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dermatrait Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
No GST registration is on our record for Dermatrait Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dermatrait Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Gouri Ojha was appointed as Director on 04 May 2021.
Frequently asked questions
Dermatrait Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 May 2021 (5+ years old) and is registered under CIN U24239DL2021PTC380797.
Dermatrait Pharmaceuticals has 2 current directors:
- Vinay Kumar Jha - Director
- Gouri Ojha - Director
The latest financial statements of Dermatrait Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Dermatrait Pharmaceuticals is U24239DL2021PTC380797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dermatrait Pharmaceuticals was incorporated on 04 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dermatrait Pharmaceuticals by revenue are Apricus Pharmaceuticals Private Limited, Elmus Pharmaceuticals Private Limited, Nevariss Pharmaceuticals Private Limited, Restogal Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gouri Ojha was appointed as Director on 04 May 2021. Vinay Kumar Jha was appointed as Director on 04 May 2021.
Yes, Dermatrait Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0013405).
The registered office of Dermatrait Pharmaceuticals is at 6336 2nd Floor Najafgarh Road Industrial Area New Delhi, Delhi, India – 110015.
Dermatrait Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Dermatrait Pharmaceuticals can be reached at its registered office: 6336 2nd Floor Najafgarh Road Industrial Area New Delhi, Delhi, India – 110015.

